| Expression pattern: |
UP |
| Associated gene: |
Wnt5a, beta-catenin, GSK-3beta, p-beta-catenin, c-Myc, cyclin D1, Bcl2, Bax |
| Associated microRNA: |
miR-139-3p |
| Biological function: |
promotes glioma cell proliferation, migration and invasion; inhibits apoptosis; promotes GICs sphere formation/self-renewal; promotes tumorigenesis in vivo |
| Molecular mechanism: |
ceRNA sponging of miR-139-3p to upregulate Wnt5a and activate Wnt/beta-catenin signaling |
| Biological pathway or process: |
Wnt/beta-catenin (promotes); proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); stemness (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Luciferase Reporter Assay; Transfection; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model |
| Clinical significance: |
circKIF4A may be a potential target for clinical treatment of glioma. |
| Description: |
circKIF4A is up-regulated in glioma tissues and cell lines and promotes malignant phenotypes (proliferation, migration/invasion, stem-like sphere formation) while inhibiting apoptosis. Mechanistically, it sponges miR-139-3p to upregulate Wnt5a and activate Wnt/beta-catenin signaling, enhancing tumor growth in xenograft models. |
| Confidence score: |
0.6917 |